Rigel Pharmaceuticals Raises FY2025 Sales Guidance from $210.000M-$220.000M to $285.000M-$290.000M vs $281.095M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Rigel Pharmaceuticals (NASDAQ:RIGL) raises FY2025 sales outlook from $210.000 million-$220.000 million to $285.000 million-$290.000 million vs $281.095 million estimate.
Rigel Pharmaceuticals (NASDAQ:RIGL) raises FY2025 sales outlook from $210.000 million-$220.000 million to $285.000 million-$290.000 million vs $281.095 million estimate.